| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.EURONEURO.2012.03.003 |
| P698 | PubMed publication ID | 22503785 |
| P50 | author | David Taylor | Q55762444 |
| Rasmus Røge | Q28812066 | ||
| P2093 | author name string | Jimmi Nielsen | |
| Holger J Sørensen | |||
| Ole Schjerning | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 818-824 | |
| P577 | publication date | 2012-04-14 | |
| P1433 | published in | European Neuropsychopharmacology | Q15286536 |
| P1476 | title | Geographical and temporal variations in clozapine prescription for schizophrenia | |
| P478 | volume | 22 |
| Q92588785 | Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review |
| Q46815534 | An association between autumn birth and clozapine treatment in patients with schizophrenia: a population-based analysis. |
| Q47586829 | Antipsychotic polypharmacy prescribing and risk of hospital readmission |
| Q47566406 | Association between global functioning at first schizophrenia diagnosis and treatment resistance. |
| Q45393472 | Clozapine and gastro-oesophageal reflux disease (GORD) - an investigation of temporal association. |
| Q40815632 | Clozapine treatment and discontinuation in Iceland: A national longitudinal study using electronic patient records |
| Q50618508 | Clozapine use pattern in persons with and without treatment for Parkinson's disease in real-world conditions: a naturalistic study in a community-based sample. |
| Q31115350 | Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis. |
| Q38840211 | Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use. |
| Q38950803 | Comparison of treatment patterns in schizophrenia between China and Japan (2001-2009). |
| Q64330478 | Delayed Initiation of Clozapine Continues to Be a Substantial Clinical Concern |
| Q39302471 | Discontinuation of clozapine: a 15-year naturalistic retrospective study of 320 patients. |
| Q47814213 | Factors associated with subjective side-effects during clozapine treatment |
| Q89804908 | Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database |
| Q41628681 | Fusing Sensor Paradigms to Acquire Chemical Information: An Integrative Role for Smart Biopolymeric Hydrogels. |
| Q39446994 | Geographical Variation in Antipsychotic Drug Use in Elderly Patients with Dementia: A Nationwide Study |
| Q40041318 | Geographical disparities in prescription practices of lithium and clozapine: a community-based study |
| Q36517570 | Geographical epidemiology of antibacterials in the preschool age. |
| Q44017981 | Involuntary treatment of schizophrenia patients 2004-2010 in Denmark |
| Q46866348 | Is disorganized schizophrenia a predictor of treatment resistance? Evidence from an observational study |
| Q50134375 | Pathway to clozapine use: a comparison between a patient cohort from New Zealand and a cohort from the United Kingdom |
| Q37042072 | Predictors of long-term (≥6months) antipsychotic polypharmacy prescribing in secondary mental healthcare |
| Q38902512 | Predictors of treatment resistance in patients with schizophrenia: a population-based cohort study |
| Q55475785 | Prescription and Underprescription of Clozapine in Dutch Ambulatory Care. |
| Q92424792 | Psychotropic medication treatment patterns in community-dwelling schizophrenia in China: comparisons between rural and urban areas |
| Q50915127 | Reliable clinical serum analysis with reusable electrochemical sensor: Toward point-of-care measurement of the antipsychotic medication clozapine. |
| Q38717462 | Risk of diabetes and dyslipidemia during clozapine and other antipsychotic drug treatment of schizophrenia in Iceland. |
| Q100945924 | Temporal trends in clozapine use at time of discharge among people with schizophrenia at two public psychiatric hospitals in Taiwan, 2006-2017 |
| Q38662839 | The association between season of birth, age at onset, and clozapine use in schizophrenia |
| Q35857645 | The clinical potentials of adjunctive fluvoxamine to clozapine treatment: a systematic review |
| Q28079065 | Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics |
| Q38948958 | Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses. |
| Q38736547 | Worldwide Differences in Regulations of Clozapine Use. |
Search more.